"
Molecular Docking of 4-Tert-buthyl-bis-(2,6-thiomorpholin-4-ylmethyl)-1-phenol (LQM319) on Fas Receptor (CD95)"
written by Oscar Zuñiga, Víctor H. Vázquez, Ana María Velázquez, Víctor H. Abrego, Sandra Díaz-Barriga Arceo, Patricia Ramírez, Roberto Díaz, Enrique Angeles,
published by
Journal of Cancer Therapy,
Vol.4 No.1, 2013
has been cited by the following article(s):
|
[1]
|
Short Fragmented Peptides from Pardachirus Marmoratus Exhibit
Stronger Anticancer Activities in In Silico Residue Replacement and
Analyses
Current Drug Discovery Technologies,
2024
DOI:10.2174/0115701638290855240207114727
|
|
|
|
|
[2]
|
Hypoxic Cardioprotection by New Antihypertensive Compounds in High Salt-Diet Hypertensive Rats: Glucose Transport Participation and Its Possible Pathway
International Journal of Molecular Sciences,
2024
DOI:10.3390/ijms25168812
|
|
|
|